- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06243601
Effect of Aloe Vera Gel as an Intra Canal Medicament
January 29, 2024 updated by: Islamabad Medical and Dental College
Effect of Aloe Vera Gel as an Intra Canal Medicament in Patients With Asymptomatic Periapical Lesions.
Methodology: Fresh AVG will be prepared.
It will be placed as intracanal medicament after cleaning and shaping in patients with asymptomatic periapical lesions in group A while in group B (control group) no intracanal medicament will be placed.
Patient will be recalled for one week and three week follow ups and in case of no clinical signs and symptoms endodontic procedure will be completed.
In case of pain normal routine procedure will be followed.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Federal
-
Islamabad, Federal, Pakistan, 44000
- Recruiting
- Islamabad Dental Hospital
-
Contact:
- Urooj Khan, BDS
- Phone Number: +923137863339
- Email: uroojkhan1996@yahoo.com
-
Contact:
- Saima Azam, BDS,FCPS
- Phone Number: 00923005350740
- Email: saima.azam@iideas.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Both male and female patients presenting with asymptomatic periapical lesions in permanent teeth
Exclusion Criteria:
History of allergy to AVG
- Comorbidities likely to impair healing
- Pregnant women
- History of previous endodontic treatment in the same tooth
- Presence of pulp calcification
- Internal or external root resorption
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
|
A fresh aloe vera (Aloe Barbadensis) leaf will be plucked from the plant.
The leaf will be washed with normal saline, peeled with scalpel and the inner gel will be blended in a blender to convert it into a watery consistency.
The solution will be stored in an autoclaved flask.
|
No Intervention: Control Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence or absence of signs and symptoms of the patient
Time Frame: One week and 3 weeks
|
Patients in both the groups will be recalled after one week. They will be assessed clinically for either presence or absence of signs and symptoms.
|
One week and 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2023
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
November 15, 2024
Study Registration Dates
First Submitted
January 29, 2024
First Submitted That Met QC Criteria
January 29, 2024
First Posted (Estimated)
February 6, 2024
Study Record Updates
Last Update Posted (Estimated)
February 6, 2024
Last Update Submitted That Met QC Criteria
January 29, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- IslamabadDentalHospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aloe vera Gel
-
NHS LothianUniversity of EdinburghWithdrawnInjuries and WoundsUnited Kingdom
-
Universidad Autonoma de Nuevo LeonCompleted
-
Ospedale Sandro Pertini, RomaCompletedAloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)
-
Cairo UniversityUnknown
-
Government Dental College and Research Institute...CompletedChronic Periodontitis
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
Ain Shams UniversityRecruitingRadiation MucositisEgypt
-
Marilia Medicine SchoolCompleted
-
University of MemphisMannatechCompletedMicrobiome | Immune FunctionUnited States
-
Government College of Dentistry, IndoreUnknown